Kidney function tests
Kidney Function Overview
The kidneys perform vital functions essential for maintaining overall body homeostasis. Their primary role is to filter blood, selectively removing waste products (like urea, creatinine) and excess substances while retaining necessary components like proteins, glucose, and essential electrolytes. This process ensures the stability of blood composition.
Key kidney functions assessed by laboratory tests include:
- Filtration: Removal of waste and excess fluid from blood (Glomerular Filtration Rate - GFR).
- Reabsorption: Returning essential substances from the filtrate back to the blood.
- Secretion: Actively transporting certain waste products from blood into the urine.
- Concentrating and Diluting Ability (Osmoregulation): Adjusting urine concentration to maintain body water balance.
- Acid-Base Balance Regulation: Excreting acids and reabsorbing bicarbonate.
- Electrolyte Balance Regulation.
- Endocrine Functions: Producing hormones like erythropoietin and renin, and activating Vitamin D.
Kidney function tests aim to evaluate how well the kidneys are performing these tasks.
Assessing Renal Osmoregulation (Concentrating/Diluting Ability)
One fundamental function of the kidneys is osmoregulation – the ability to adjust the concentration of urine relative to plasma to maintain water balance. This involves concentrating the urine when the body needs to conserve water (e.g., dehydration) and diluting it when there is excess water.
This complex process primarily occurs in the loop of Henle, distal tubules, and collecting ducts, under the influence of Antidiuretic Hormone (ADH). It depends on efficient nephron function, adequate renal blood flow, and proper neurohumoral control.
Impairment of the kidney's ability to concentrate or dilute urine appropriately is an early sign of renal dysfunction. Simple tests assessing urine concentration (like specific gravity or osmolality measurements under specific conditions) can provide valuable functional information.
The Zimnitsky Test
The Zimnitsky test is a classic, though less commonly used today, functional kidney test designed specifically to assess the kidney's ability to concentrate and dilute urine over a 24-hour period under normal living conditions.
Procedure
The test involves collecting urine in separate containers at specific time intervals over a full 24-hour cycle, typically every three hours (8 portions). The patient follows their normal diet and fluid intake routine (no specific water loading or restriction is imposed).
For each collected urine portion, the laboratory measures:
- Volume
- Relative density (Specific Gravity)
Sometimes, total solute excretion (like sodium chloride and urea) might be measured in pooled daytime and nighttime samples, but the core of the test focuses on volume and specific gravity fluctuations.
The total urine volume excreted over 24 hours is compared to the patient's recorded fluid intake during that period.
Interpretation
Normal kidney function is indicated by:
- Volume Variation: Significant fluctuation in the volume of individual urine portions throughout the day.
- Specific Gravity Variation: Wide fluctuation in specific gravity between different portions, demonstrating the ability to both concentrate and dilute. Typically ranges might span from below 1.005 (dilute) to above 1.020-1.025 (concentrated) in at least one sample.
- Day/Night Ratio: Daytime urine volume should significantly exceed nighttime volume (typically a ratio of 3:1 or 4:1).
- Concentration Ability: At least one sample should show good concentration (e.g., SG ≥ 1.018 or 1.020).
- Dilution Ability: At least one sample should show good dilution (e.g., SG ≤ 1.004 or 1.005).
- Total Volume: Total 24-hour urine output should appropriately reflect fluid intake (e.g., roughly 65-80% of intake).
- SG Range Difference: The difference between the highest and lowest specific gravity measured should be significant (e.g., ≥ 0.007 or often cited as ≥ 0.012-0.016).
Pathological findings suggestive of impaired renal concentrating/diluting ability include:
- Isosthenuria: Fixation of specific gravity in a narrow range, typically around 1.007–1.012 (similar to glomerular filtrate), indicating loss of both concentrating and diluting ability. Characteristic of advanced chronic kidney disease.
- Hyposthenuria: Persistently low specific gravity (< 1.010), indicating impaired concentrating ability (seen in diabetes insipidus, chronic pyelonephritis, early chronic renal failure).
- Nocturia: Predominance of nighttime urine volume over daytime volume, often an early sign of impaired concentrating ability or conditions like heart failure or BPH.
- Monotonous Volume/Density: Lack of significant variation in volume or specific gravity between portions.
- Polyuria: Consistently large volumes in each portion or overall (if not due to high intake).
While informative, the Zimnitsky test is cumbersome due to the multiple collections and has largely been replaced by simpler assessments like measuring specific gravity or osmolality on a first morning urine sample (for concentration) or after water loading (for dilution), and by GFR estimation.
Renal Clearance Concept
Renal clearance methods provide a more quantitative assessment of specific kidney functions, particularly glomerular filtration. Renal clearance of a substance represents the theoretical volume of plasma (or blood) from which that substance is completely removed (cleared) by the kidneys per unit of time (usually measured in ml/min).
Types of Renal Clearance
Depending on how the kidneys handle a substance, its clearance reflects different aspects of renal function:
- Filtration Clearance: Measured using substances that are freely filtered by the glomeruli but are neither reabsorbed nor secreted by the tubules (e.g., inulin - the gold standard, or approximately, endogenous creatinine). This clearance value directly measures or estimates the Glomerular Filtration Rate (GFR).
- Excretion Clearance (Renal Plasma Flow): Measured using substances that are both freely filtered and almost completely secreted by the tubules from the blood that *doesn't* get filtered (e.g., para-aminohippurate - PAH). This clearance approximates the Renal Plasma Flow (RPF).
- Reabsorption Clearance: Substances freely filtered but then completely reabsorbed by the tubules (e.g., glucose under normal blood levels, most proteins). Their clearance is normally zero. When blood levels exceed the tubular reabsorptive capacity (Tm), the substance appears in the urine, and its clearance can be measured to assess maximal tubular reabsorption capacity.
- Mixed Clearance: Substances that are filtered and then partially reabsorbed and/or partially secreted (e.g., urea). Their clearance reflects a combination of these processes and is less straightforward to interpret than pure filtration or excretion clearance.
Clearance Calculation
The standard formula to calculate the renal clearance (C) of a substance is:
C (ml/min) = [U × V] / P
Where:
- U = Concentration of the substance in urine (e.g., mg/ml or mg/dL)
- V = Urine flow rate (volume of urine produced per minute, ml/min) - calculated from a timed urine collection (e.g., 24-hour volume divided by 1440 minutes)
- P = Concentration of the substance in plasma (or serum) (in the same units as U, e.g., mg/ml or mg/dL)
Clearance values are influenced by age, sex, body size, and the extent of kidney damage.
Common Markers for Kidney Function
While various substances can be used for clearance studies, the most commonly measured endogenous markers in clinical practice to assess renal function (specifically GFR) are creatinine and, to a lesser extent, urea (BUN).
- Creatinine: Produced from muscle metabolism at a relatively constant rate, primarily cleared by glomerular filtration with some tubular secretion. Serum creatinine levels rise as GFR falls. Creatinine clearance approximates GFR but slightly overestimates it due to secretion, especially when GFR is low. eGFR formulas based on serum creatinine are widely used.
- Urea (BUN): End product of protein metabolism, cleared by filtration and significant tubular reabsorption (influenced by hydration). Serum BUN levels increase with decreased GFR but are also heavily influenced by protein intake, hydration status, and liver function, making it a less specific marker of GFR than creatinine alone.
Elevated serum creatinine and urea (BUN) levels are hallmarks of renal dysfunction and are key indicators of renal failure. Creatinine typically rises earlier and is considered a more reliable marker of GFR changes than urea.
References
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). (n.d.). The Kidneys and How They Work. NIH. Retrieved from https://www.niddk.nih.gov/health-information/kidney-disease/kidneys-how-they-work
- Hall, J. E., & Guyton, A. C. (2020). *Guyton and Hall Textbook of Medical Physiology* (14th ed.). Elsevier. (Chapters on Renal Physiology and Urine Formation).
- Rose, B. D., & Post, T. W. (2001). *Clinical Physiology of Acid-Base and Electrolyte Disorders* (5th ed.). McGraw-Hill. (Chapter on Renal Regulation of Water Balance).
- Lamb, E. J., Jones, G. R. D., & Davison, A. M. (Eds.). (2010). *Clinical Biochemistry and Metabolic Medicine* (8th ed.). Hodder Arnold. (Chapter on Renal Function).
- McPherson, R. A., & Pincus, M. R. (Eds.). (2017). *Henry's Clinical Diagnosis and Management by Laboratory Methods* (23rd ed.). Elsevier. (Chapter on Renal Function and Urinalysis).
See also
- Complete blood count (CBC):
- Urinalysis:
- Cerebrospinal fluid (CSF) analysis
- Biochemical markers of bone remodeling and diseases
- Markers of autoimmune connective tissue diseases (CTDs)
- Antiphospholipid syndrome (APS)
- Lipoprotein(a), Lp(a)
- Semen analysis (sperm count test)
- Tumor markers tests (cancer biomarkers):
- β-2 microglobulin (beta-2)
- Alpha-fetoprotein (AFP)
- Squamous cell carcinoma antigen (SCC)
- S100 protein tumormarker
- Calcitonin
- Mucin-like carcinoma-associated antigen (MCA)
- Neuron-specific enolase (NSE)
- Prostate-specific antigen (PSA) test
- Cancer associated antigen 549 (CA 549)
- CA 19-9, CA 72-4, CA 50, CA 15-3 and CA 125 tumor markers (cancer antigens)
- Carcinoembryonic antigen (CEA)
- Thyroglobulin (Tg)
- Tissue polypeptide antigens (ТРА, TPS)
- Cytokeratin-19 fragment (CYFRA 21-1)
- Human chorionic gonadotrophin (hCG)